We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+4.96%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$904M
AUM Growth
+$40.3M
Cap. Flow
-$112K
Cap. Flow %
-0.01%
Top 10 Hldgs %
51.47%
Holding
194
New
10
Increased
69
Reduced
70
Closed
10

Top Buys

Rank Stock Value
1
FNDX icon
Schwab Fundamental US Large Company Index ETF
FNDX
+$13.7M
2
FNDF icon
Schwab Fundamental International Large Company Index ETF
FNDF
+$9.31M
3
AVUV icon
Avantis US Small Cap Value ETF
AVUV
+$5.28M
4
VTEB icon
Vanguard Tax-Exempt Bond Index Fund
VTEB
+$4.63M
5
FNDE icon
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
+$4.39M

Top Sells

Rank Stock Value
1
GSIE icon
Goldman Sachs ActiveBeta International Equity ETF
GSIE
+$12.3M
2
GSLC icon
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
+$8.15M
3
SCHB icon
Schwab US Broad Market ETF
SCHB
+$3.99M
4
AVUS icon
Avantis US Equity ETF
AVUS
+$3.64M
5
INTF icon
iShares International Equity Factor ETF
INTF
+$2.93M

Sector Composition

Rank Sector Weight
1 Miscellaneous 90.87%
2 Technology 4.06%
3 Healthcare 1.11%
4 Financials 1.02%
5 Consumer Discretionary 0.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TARS icon
151
Tarsus Pharmaceuticals
TARS
$3.15B
$267K 0.03%
14,750
+450
+3% +$7.15K
PSX icon
152
Phillips 66
PSX
$97.4B
$263K 0.03%
2,753
-504
-15% -$49K
XBI icon
153
State Street SPDR S&P Biotech ETF
XBI
$11.3B
$261K 0.03%
3,135
+500
+19% +$41.8K
PM icon
154
Philip Morris
PM
$299B
$260K 0.03%
2,660
+34
+1% +$3.25K
IQV icon
155
IQVIA
IQV
$43.1B
$258K 0.03%
1,150
+76
+7% +$15.3K
LOW icon
156
Lowe's Companies
LOW
$117B
$258K 0.03%
1,143
– –
MRO
157
DELISTED
Marathon Oil Corporation
MRO
$258K 0.03%
+11,200
New +$264K
UNH icon
158
UnitedHealth
UNH
$353B
$255K 0.03%
531
+5
+1% +$2.44K
VV icon
159
Vanguard Morningstar Large-Cap ETF
VV
$54.3B
$250K 0.03%
1,231
– –
TLTD icon
160
Northern Trust Morningstar Developed Markets ex-US Factor Tilt ETF
TLTD
$690M
$248K 0.03%
3,823
+38
+1% +$2.48K
GS icon
161
Goldman Sachs
GS
$301B
$245K 0.03%
+759
New +$250K
LIN icon
162
Linde
LIN
$226B
$244K 0.03%
641
– –
IG icon
163
Principal Investment Grade Corporate Active ETF
IG
$202M
$242K 0.03%
11,762
– –
INGN icon
164
Inogen
INGN
$146M
$238K 0.03%
20,611
– –
PYPL icon
165
PayPal
PYPL
$45.9B
$237K 0.03%
3,554
+115
+3% +$7.84K
BMY icon
166
Bristol-Myers Squibb
BMY
$136B
$224K 0.02%
3,510
-65
-2% -$4.36K
CELH icon
167
Celsius Holdings
CELH
$8.35B
$224K 0.02%
+4,500
New +$179K
CRM icon
168
Salesforce
CRM
$211B
$224K 0.02%
1,058
+10
+1% +$2.04K
PXH icon
169
Invesco FTSE RAFI Emerging Markets ETF
PXH
$2.01B
$223K 0.02%
11,986
– –
RCL icon
170
Royal Caribbean
RCL
$74.7B
$218K 0.02%
+2,100
New +$165K
AGNT
171
AGNT Inc
AGNT
$709M
$214K 0.02%
10,568
-25,708
-71% -$384K
AZN icon
172
AstraZeneca
AZN
$252B
$213K 0.02%
1,490
-34
-2% -$5K
LDP icon
173
Cohen & Steers Duration Preferred & Income Fund
LDP
$601M
$182K 0.02%
10,000
– –
USBC
174
USBC Inc
USBC
$165M
$152K 0.02%
3,750
+500
+15% +$21.7K
KYN icon
175
Kayne Anderson Energy Infrastructure Fund
KYN
$2.51B
$139K 0.02%
+17,027
New +$140K
4 5 6
7
8

Similar funds

MBA
Maple-Brown Abbott Barangaroo, Australia $1.47B AUM 27.26% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
AP
Adero Partners Pleasanton, California $1.53B AUM 5.52% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return
PAME
Parvus Asset Management Europe London, United Kingdom $1.67B AUM

Callan Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Callan Capital held 194 positions worth $904M, up 4.7% from $864M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Callan Capital's Q2 2023 filing shows 10 new, 69 increased, 70 reduced and 10 closed positions. Its largest new stake was iShares Russell 2000 ETF: 4,571 shares worth $856K. The largest sale was Goldman Sachs ActiveBeta International Equity ETF, an estimated $12.3M.

By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, up from 91% a quarter earlier, followed by Technology and Healthcare.

  • Callan Capital's largest Q2 2023 buy was iShares Russell 2000 ETF: 4,571 shares worth $856K.
  • Callan Capital added most to Schwab Fundamental US Large Company Index ETF in Q2 2023, an estimated $13.7M increase.
  • Callan Capital's biggest Q2 2023 reduction was Goldman Sachs ActiveBeta International Equity ETF, cutting an estimated $12.3M.
  • Callan Capital fully exited NextGen Healthcare, Inc. Common Stock in Q2 2023, selling an estimated $1.82M.
  • Callan Capital's ten largest holdings make up 51% of its $904M portfolio in Q2 2023.
  • Callan Capital opened 10 new positions and closed 10 in Q2 2023.
  • Callan Capital's portfolio value rose 4.7% quarter-over-quarter to $904M.

Based on Callan Capital's 13F filing for Q2 2023, filed 4 Aug 2023.